Literature DB >> 11216996

Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte.

K Tanaka1, M Honda, T Takabatake.   

Abstract

OBJECTIVES: We analyzed the regulatory function of reactive oxygen species (ROS) on the hypertrophic signaling in adult rat cardiac myocytes:
BACKGROUND: The ROS regulate mitogenic signal transduction in various cell types. In neonatal rat cardiac myocyte, antioxidants have been shown to inhibit cardiac hypertrophy, and ROS are suggested to modulate the hypertrophic signaling. However, the conclusion may not reflect the situation of mature heart, because of the different natures between neonatal and adult cardiac myocytes.
METHODS: Cultured adult rat cardiac myocytes were stimulated with endothelin-1 (ET-1) or phenylephrine (PE), and intracellular ROS levels, the activities of mitogen-activated protein kinases (MAPKs; ERK, p38, and JNK), and 3H-phenylalanine incorporation were examined. We also examined the effects of antioxidant pretreatment of myocytes on MAPK activities and cardiac hypertrophy to analyze the modulatory function of redox state on MAPK-mediated hypertrophic signaling.
RESULTS: The ROS levels in ET-1- or PE-stimulated myocytes were maximally increased at 5 min after stimulation. The origin of ROS appears to be from NADH/NADPH oxidase, because the increase in ROS was suppressed by pretreatment of myocytes with NADH/NADPH oxidase inhibitor diphenyleneiodonium. Extracellular signal-regulated kinase (ERK) activity was increased by the stimulation of ET-1 or PE. In contrast, p38 and c-Jun-N-terminal protein kinase (JNK) activities did not change after these stimulations. Antioxidant treatment of myocytes suppressed the increase in ROS and blocked ERK activation and the subsequent cardiac hypertrophy induced by these stimuli.
CONCLUSIONS: These data demonstrate that ROS mediate signal transduction of cardiac hypertrophy induced by ET-1 or PE in adult rat cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11216996     DOI: 10.1016/s0735-1097(00)01123-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  61 in total

1.  Tom70 serves as a molecular switch to determine pathological cardiac hypertrophy.

Authors:  Jun Li; Man Qi; Changming Li; Dan Shi; Dasheng Zhang; Duanyang Xie; Tianyou Yuan; Jing Feng; Yi Liu; Dandan Liang; Xinran Xu; Jinjin Chen; Liang Xu; Hong Zhang; Jiangchuan Ye; Fei Lv; Jian Huang; Luying Peng; Yi-Han Chen
Journal:  Cell Res       Date:  2014-07-15       Impact factor: 25.617

2.  The cytoprotective impact of yes-associated protein 1 after ischemia-reperfusion injury in AC16 human cardiomyocytes.

Authors:  Kashif Khan; Georges Makhoul; Bin Yu; Adel Schwertani; Renzo Cecere
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-29

3.  Endogenous endothelin 1 mediates angiotensin II-induced hypertrophy in electrically paced cardiac myocytes through EGFR transactivation, reactive oxygen species and NHE-1.

Authors:  María V Correa; Mariela B Nolly; Claudia I Caldiz; Gladys E Chiappe de Cingolani; Horacio E Cingolani; Irene L Ennis
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

Review 4.  Role of endothelin-1 in hypertension.

Authors:  Marc Iglarz; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

5.  Adrenergic signaling regulates mitochondrial Ca2+ uptake through Pyk2-dependent tyrosine phosphorylation of the mitochondrial Ca2+ uniporter.

Authors:  Jin O-Uchi; Bong Sook Jhun; Shangcheng Xu; Stephen Hurst; Anna Raffaello; Xiaoyun Liu; Bing Yi; Huiliang Zhang; Polina Gross; Jyotsna Mishra; Alina Ainbinder; Sarah Kettlewell; Godfrey L Smith; Robert T Dirksen; Wang Wang; Rosario Rizzuto; Shey-Shing Sheu
Journal:  Antioxid Redox Signal       Date:  2014-06-25       Impact factor: 8.401

6.  The influence of endogenously generated reactive oxygen species on the inotropic and chronotropic effects of adrenoceptor and ET-receptor stimulation.

Authors:  Carsten Sand; Stephan L M Peters; Martin Pfaffendorf; Pieter A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-06       Impact factor: 3.000

7.  Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice.

Authors:  Xin Xu; Xinli Hu; Zhongbing Lu; Ping Zhang; Lin Zhao; Jerry L Wessale; Robert J Bache; Yingjie Chen
Journal:  J Card Fail       Date:  2008-07-10       Impact factor: 5.712

8.  Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarction.

Authors:  Elza D van Deel; Zhongbing Lu; Xin Xu; Guangshuo Zhu; Xinli Hu; Tim D Oury; Robert J Bache; Dirk J Duncker; Yingjie Chen
Journal:  Free Radic Biol Med       Date:  2007-12-15       Impact factor: 7.376

9.  Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.

Authors:  Rudolf A de Boer; Saraswati Pokharel; Markus Flesch; Derk A van Kampen; Albert J H Suurmeijer; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen; Yigal M Pinto
Journal:  J Mol Med (Berl)       Date:  2004-08-20       Impact factor: 4.599

10.  Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy.

Authors:  Tzu-Hurng Cheng; Ju-Chi Liu; Heng Lin; Neng-Lang Shih; Yen-Ling Chen; Meng-Ting Huang; Paul Chan; Ching-Feng Cheng; Jin-Jer Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.